Beyond the Price Tag: The Hidden Financial Dynamics of Cell and Gene Therapies Impacting Payers
Time: 11:30 am
day: Conference Day Two
Details:
- Using Milliman’s proprietary closed claims dataset: the payer’s perspective on the patient journey associated with cell and gene therapy treatment
- Exploring differences in treatment episodes and payer costs for ex vivo versus in vivo therapies and the potential impacts on the access ecosystem
- Unpacking the distinct roles of primary and secondary/re-insurers related to treatment costs to drive understanding of their perspectives and financial exposure
